View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
March 15, 2011

Japanese Quake Could Disrupt Medical Device Sales

US medical device makers could face disruptions to their sales following the earthquake and tsunami that hit Japan last week, Deutsche Bank has warned. Edwards Lifesciences Corporation, Boston Scientific and St Jude Medical are among the medical device makers with most exposure in Japa

By cms admin

US medical device makers could face disruptions to their sales following the earthquake and tsunami that hit Japan last week, Deutsche Bank has warned.

Edwards Lifesciences Corporation, Boston Scientific and St Jude Medical are among the medical device makers with most exposure in Japan, its report noted.

Heart-valve manufacturer Edwards generates 17% of its sales in the country, where it has an office and distribution operation.

Boston Scientific generates 12% of its sales in Japan, while St Jude’s generates 11%. Stryker Corporation and Becton Dickinson generate 10% and 6% of their sales respectively.

Becton Dickinson’s syringe manufacturing facility in Fukushima has been temporarily closed in light of the damage of the area’s nuclear power complex, which was caused by the earthquake.

Other device makers with significant sales in Japan include Zimmer Holdings (9%), Covidien (8%), Baxter International (7%), Medtronic (6%) and CR Bard (5%).

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management